171 results about "Protein detection" patented technology

The invention belongs to the technical field of immunochemistry, and particularly relates to an anti-PR recombinant rabbit monoclonal antibody and application thereof.The anti-PR recombinant rabbit monoclonal antibody comprises a heavy chain variable region and a light chain variable region, and the amino acid sequence of the heavy chain variable region is shown as SEQ ID NO: 4; the amino acid sequence of the light chain variable region is as shown in SEQ ID NO: 5. The invention also relates to a nucleotide sequence for coding the anti-PR recombinant rabbit monoclonal antibody, a recombinant plasmid or an expression vector, a preparation method, application of the anti-PR recombinant rabbit monoclonal antibody in a PR protein detection method or device, and the like. The PR recombinant rabbit monoclonal antibody disclosed by the invention has the characteristics of good specificity, strong positive signal and the like, so that scoring is easier in IHC staining, and cancer detection and distinguishing are more accurate.

The invention belongs to the technical field of bioengineering, and particularly relates to a nucleic acid aptamer specifically bound with MMLV, and the nucleotide sequence of the nucleic acid aptamer is as shown in SEQ ID NO.1 or SEQ ID NO.2; the nucleic acid aptamer capable of being specifically bound with MMLV is obtained through screening on the basis of the SELEX technology, has high affinity for MMLV protein, can be applied to MMLV protein enrichment reagents, MMLV protein separation reagents, MMLV protein detection reagents, test paper and biosensors, and facilitates identification and activity research of the MMLV protein.

The invention belongs to the technical field of biological detection, and relates to an antibody composition aiming at human pS129-alpha-Syn protein detection and application thereof, and the antibody composition comprises a targeted pS129-alpha-Syn protein phosphorylation antibody and a targeted human alpha-synuclein N-terminal antibody. Meanwhile, based on the antibody composition for detecting the human pS129-alpha-Syn protein, the invention further provides a kit for early diagnosis of the Parkinson's disease. The invention provides an antibody composition aiming at human pS129-alpha-Syn protein detection and application of the antibody composition. The antibody composition is higher in detection specificity and sensitivity.

The invention belongs to the technical field of biological detection, and particularly relates to a specific monoclonal antibody for AKK bacterium active protein P9, a detection kit and application of the specific monoclonal antibody. The antibody pair is 7G4 and 8B2, the amino acid sequence of a heavy chain variable region of the 7G4 is SEQ ID NO.2, and the amino acid sequence of a light chain variable region of the 7G4 is SEQ ID NO.4; the amino acid sequence of the 8B2 heavy chain variable region is SEQ ID NO.6, and the amino acid sequence of the 8B2 light chain variable region is SEQ ID NO.8. The antibody pair has strong specificity and high affinity, and can accurately recognize different antigen epitopes of the P9 protein. A colloidal gold detection and double-antibody sandwich ELISA detection system constructed based on the kit adapts to a complex matrix and various process treatment samples, is stable and reliable in detection, has qualitative and quantitative capabilities, can be used for scenes of P9 protein detection, fermentation monitoring, quality control and the like, and solves the problems of insufficient specificity, poor adaptability and the like in the prior art.

The invention discloses a protein quantitative detection method which comprises the following steps: respectively constructing a capture probe for capturing antibody coupling magnetic beads and oligonucleotides and a detection probe for detecting antibody coupling oligonucleotides through a biorthogonal chemical coupling method; then, target protein is captured by using a biorthogonal chemical coupling and magnetic bead sandwich method comprising the steps of capture probe combination, closing, washing, detection probe combination and the like, and accurate quantification of low-abundance protein in a complex sample is realized by combining a subsequent digital PCR (Polymerase Chain Reaction) technology.

The application discloses a preparation method of a VP@UiO-66-NH2 / Ag NPs composite SERS chip and application thereof in A beta protein detection, and is characterized by comprising the following steps: synthesizing a VP-graphite paper base by a chemical vapor transport method on a surface of a graphite paper to obtain a VP-graphite paper base; synthesizing a UiO-66-NH2 layer on the surface of the VP-graphite paper base by a solvothermal method to obtain a VP@UiO-66-NH2 composite base; and finally, placing the composite base in an ion sputtering instrument, uniformly sputtering silver nanoparticles on the surface of the composite base, taking out the composite base, and obtaining the VP@UiO-66-NH2 / Ag NPs composite SERS chip, wherein the VP@UiO-66-NH2 / Ag NPs composite SERS chip has the advantages of high sensitivity, good stability and uniformity, controllable preparation process, low cost, application in Alzheimer's disease biomarker detection, high specificity in identification and quantitative analysis of A beta 40 and A beta 42 proteins, fast response and good stability.

The invention relates generally to peptide biomarkers with specific ionization characteristics to directly quantify one or more target HPPD proteins in biological samples, including crop plant samples, by liquid chromatography coupled tandem mass spectrometry multiple reaction monitoring (MRM). The peptide biomarkers in combination with MRM-based methods may be used to quantify a single target protein or multiple target proteins within a crop plant, such as maize, utilizing selected peptide biomarkers either alone or in combination. The present disclosure allows for broad based, reliable quantitation in different biological matrices, including plant matrices. Also provided are different peptide biomarker combinations that can be used to perform the methods of the invention.

The invention discloses a detection method of inflammatory marker protein. According to the method, the micro-fluidic chip with a sample loading area, a buffer treatment area, a sample channel and a detection area is prepared on filter paper through wax printing; chitosan is preset in the sample loading area and is used for treating a sample, and bromothymol blue is fixed in the detection area and is used as a pH indicator. During detection, a sample is driven by a phosphate buffer solution with the pH value of 6.0 to flow to a detection area through capillary action, the C-reactive protein and the indicator are subjected to non-specific binding, so that the color of the detection area is changed from yellow to green, the length of a green developing signal is in direct proportion to the concentration of the CRP, and quantitative detection can be realized by measuring the length. The method does not need an antibody, is low in cost, is simple and convenient to operate, can complete detection within 15 minutes, has the detection limit of 1.56 ng / ml and the linear range of 5-25 ng / ml, and is suitable for rapid screening and field detection of basic medical institutions.

1. The name of the design product: storage (urine protein). 2. The use of the design product: for urine protein detection sample storage. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view.

The invention discloses a colorimetric detection method for cMyBP-C protein based on nano-enzyme activity, preparation of a bismuth selenide / nano-gold composite material and application of the bismuth selenide / nano-gold composite material in protein detection. The method comprises the following steps: performing ultrasonic stripping on a bismuth selenide block to obtain a few-layer bismuth selenide dispersion liquid; and then sequentially adding a sodium borohydride aqueous solution and a chloroauric acid aqueous solution under a stirring condition, and carrying out in-situ reduction to form gold nanoparticles loaded on the surface of bismuth selenide. The composite material has the capability of catalyzing reduction of p-nitrophenol into p-aminophenol, and the color of the solution is changed from yellow to colorless. After the cMyBP-C antibody is modified on the surface of the composite material, the catalytic activity is inhibited; after a to-be-detected sample is added, the antibody and the protein are specifically combined to cause dissociation, and the catalytic activity is recovered. The cMyBP-C protein is quantitatively detected by observing the color change of the solution or monitoring the reduction of the ultraviolet absorbance at 400 nm.

The application discloses a monoclonal antibody of a rice field eel Adam8a and a preparation method and application thereof, relates to the technical field of biological antibodies, and fills the research blank of the rice field eel Adam8a. The rice field eel Adam8a monoclonal antibody is high in specificity and titer, simple in preparation process, and controllable in cost, can be widely used for recognizing Adam8a homologous proteins in different fish ovary, and is suitable for being prepared into a fish ovary Adam8a protein detection kit, and is compared with the expression of the protein in different fish, so that the rice field eel Adam8a monoclonal antibody becomes a very convenient detection tool in the biological research of fish ovary development.

The invention relates to a synchronous detection method and system for small molecules and protein, and the synchronous detection method comprises the following steps: respectively preparing a small molecule detection antibody and a protein detection antibody marked by carboxyl fluorescent microspheres, and mixing the small molecule detection antibody and the protein detection antibody to obtain a mixed detection antibody; respectively preparing a microsphere-labeled capture micromolecule antigen and a protein antibody; preparing a microsphere array biochip with two detection areas; carrying out sample application on the microsphere-labeled captured micromolecule antigen and the protein antibody to the two detection areas; mixing a sample to be detected with the mixed detection antibody according to different proportions; slowly adding the sample mixed solution into two detection areas of the microsphere array biochip respectively; scanning and imaging the two detection areas of the microsphere array biochip respectively, identifying all fluorescent spot information in a fluorescent image, and obtaining the concentration of small molecules and proteins in a sample to be detected through a Poisson distribution principle or by establishing a standard curve. According to the invention, synchronous detection of small molecules and proteins can be realized.

The invention discloses a polyclonal antibody of panda Rbp7 protein as well as a preparation method and application thereof, and belongs to the technical field of antibodies. The first to nineteenth amino acid sequences of the panda Rbp7 protein are used as antigen polypeptides, and are specifically shown as SEQ ID No.1. After chemical synthesis or exogenous expression purification, a Balb / C mouse is immunized, and the polyclonal antibody is obtained through repeated immunization, serum titer detection and affinity chromatography purification. The titer of the antibody is not lower than 1 / 128000, the panda Rbp7 recombinant protein can be efficiently and specifically detected through WB and ELISA, the blank of a protein detection tool is filled, and reliable technical support is provided for research on the functional mechanism of the panda Rbp7 protein.

Provided is a protein detection method for detecting a protein contained in a biological tissue collected from a living body. The protein detection method comprises: a step for preparing a specimen sample by adding, to a sample containing a protein collected from a living body, antibody-carrying magnetic particles that bind to the protein, and mixing the antibody-carrying magnetic particles and the sample; a measurement step for measuring a magnetic signal corresponding to a magnetic field generated by the specimen sample by applying, to the specimen sample, a switching magnetic field in which the magnetic field direction reverses; and a detection step for detecting the protein contained in the specimen sample on the basis of the magnetic signal.

The utility model relates to the technical field of protein detection, and provides a protein pretreatment device which comprises a base, a digestion frame, an adding mechanism, a first driving part and a second driving part, the digestion frame is arranged on the base, and a plurality of digestion tube clamping holes are formed in the digestion frame; the adding mechanism is connected with the base, is positioned above the digestion frame, and is used for adding a protein detection solution into the digestion tube in the digestion tube clamping hole; the first driving part comprises a first driving end and a first fixing end, the first driving end is connected with the adding mechanism, and the first fixing end is connected with the base so as to drive the adding mechanism to move in the first direction; the second driving part comprises a second driving end and a second fixing end, the second driving end is connected with the adding mechanism, the second fixing end is connected with the base so as to drive the adding mechanism to move in the second direction, the first direction is perpendicular to the second direction, and the formed plane is parallel to the plane where the digestion tube clamping holes are located. Automatic operation is achieved, and manual operation is reduced.

The invention relates to the technical field of digital PCR detection, in particular to a single-molecule protein detection method based on digital PCR. The detection method comprises the following steps: fusing digital PCR and immune PCR, capturing an antibody through magnetic bead coupling, binding the captured antigen with a detection antibody of a nucleic acid fragment through streptavidin-biotin coupling to form a double-antibody sandwich structure, amplifying a fluorescence signal by using digital PCR amplification, and calculating to obtain the target protein concentration of a sample to be detected. Therefore, quantitative detection of the single-molecule protein is realized, and the detection limit reaches 0.395 fg / ml. The detection method is accurate in quantification and excellent in sensitivity, the detection cost can be greatly reduced, the detection efficiency is improved, the detection process is simplified, and the high requirement for equipment precision is reduced.

The present disclosure relates to the field of protein detection technology, and discloses a protein detection method based on a combined nanopore structure, comprising: a surface of a sandwich film chip is processed to form a nano-through hole, and a “hole-cavity-hole” structure is prepared. The “hole-cavity-hole” structure is driven by the electric field of the functional protein to detect the protein. The present disclosure adopts the above-mentioned protein detection method based on a combined nanopore structure, which can effectively overcome the problem of protein detection reading length caused by the limitation of nanopore space. Meanwhile, in contrast to methods that embed functional protein complexes within a phospholipid bilayer, integrating functional proteins directly into solid nanopores combines the advantages of both biological and solid systems. This approach not only relaxes the stringent environmental demands placed on the sensor but also enhances its resolution and stability.

The invention belongs to the technical field of biology, and particularly relates to application of a protein detection reagent to preparation of a reagent for predicting the treatment effect of a medicine for treating damp-heat accumulation type gouty arthritis. By detecting the expression conditions of 23 proteins provided by the invention in serum of a subject, the curative effect condition of a drug (such as a pyretic arthralgia eliminating agent) on a patient with damp-heat accumulation type gouty arthritis can be predicted, and the prediction accuracy is high and can reach 98.3%.

The utility model discloses a rapid quantitative detection kit for detecting prostate small body leaked protein, which belongs to the technical field of prostate small body leaked protein detection and comprises a kit inner box, a kit outer box is arranged on the outer side of the kit inner box, and a sealing plate is arranged on the inner side of the kit outer box. According to the utility model, through the unique design of the adjusting plate, a detector can flexibly rotate the adjusting plate according to the amount of a required solution, so that the discharge port is accurately connected with the corresponding discharge chute, and when the solution is added to a position flush with the discharge chute, the redundant solution automatically flows out from the discharge port to the outer kit for temporary storage; therefore, the problem of inaccurate solution measurement caused by factors such as human visual errors or hand shaking in a traditional measurement mode is effectively avoided, high accuracy of the solution amount added each time is ensured, a solid foundation is laid for the accuracy of detection of the prostate small body leaked protein, the reliability and repeatability of a detection result are remarkably improved, and the method is suitable for popularization and application. And detection errors caused by solution amount deviation are reduced.

The invention relates to the field of protein detection, in particular to a method for detecting phosphorylated Tau-217 protein in urine of an Alzheimer's disease patient, which comprises the following steps of: 1, collecting fresh urine in the morning by using a urine collecting container, and 2, taking out 100 microliters of urine by using a transfer pipette and adding the urine into a 5.0 ml centrifugal tube; step 3, adding 4.9 ml of a urine diluent to dilute the urine; and step 4, prefabricating tracing fluorescent microspheres and enrichment microspheres in the centrifugal tube. Step 5, repeatedly reversing and uniformly mixing, and reacting at room temperature for 8-12 hours; step 5, placing the reaction tube on a separation test tube rack with a magnet for more than 20 minutes; step 6, irradiating the test tube by using a highlighter with the wavelength of about 340nm in a dark environment to judge a result; and step 7, if a red fluorescent dot appears near the magnet in the test tube, the result is positive, otherwise, the result is negative, and the result can also be judged by measuring a fluorescence value through a luminoscope with the wavelength of 340nm. Finally, the phosphorylated Tau-217 protein is detected, and the operation threshold and the economic cost are reduced.

The invention discloses a method for analyzing serum differential expression protein characteristics of an AQP4-IgG positive NMOSD patient, and relates to the technical field of differential expression protein characteristic analysis, and the method comprises the following steps: S1, collecting a serum sample of a to-be-detected subject; s2, carrying out protein detection on the serum sample to obtain expression level data of at least one or more of PRDX2, CLU, ECM1, CFD, GPI and S100A8, wherein the expression level data is one or more of PRDX2, CLU, ECM1, CFD, GPI and S100A8; s3, carrying out comparative analysis on the expression level of the serum protein and a pre-established AQP4-IgG positive NMOSD serum protein expression characteristic reference standard; according to the method for auxiliary diagnosis of the AQP4-IgG positive neuromyelitis optica pedigree disease provided by the invention, a judgment mode capable of reflecting molecular characteristics of the AQP4-IgG positive neuromyelitis optica pedigree disease is constructed by carrying out conjoint analysis on various serum protein expression characteristics related to immunoregulation, inflammatory response, complement activation and metabolism; therefore, the problem of insufficient detection stability of a single biomarker is avoided.

The invention relates to the technical field of biological medicines, and particularly discloses a high-grade serous ovarian cancer (HGSOC) treatment strategy based on ANXA6 protein detection and regulation. The invention provides a method for evaluating the sensitivity of a patient to cisplatin chemotherapy by detecting the expression level of ANXA6 protein or a specific modification site thereof, and a composition comprising inhibiting the function of ANXA6 or combining with cisplatin. In addition, the invention also relates to a medicine application for enhancing the chemotherapy effect by regulating the activity of ANXA6 related modifying enzyme.

The invention relates to the technical field of biological detection, in particular to a dry-state hydrogel-based plasma-Fabry-Perot cavity biological detector as well as a preparation method and application thereof. Compared with ELISA and other immunological detection methods depending on chemical tags and signal amplification, the method does not need a signal amplification process and shortens the detection time. The integrated plasma interlayer thickness sensing structure provided by the invention realizes direct signal reading after sample incubation is finished. According to the invention, the hydrogel is used as a sensing interlayer, and the hydrogel is used as a three-dimensional medium, so that a larger thickness change can be generated in a spatial scale. The biological detector can still keep relatively high specificity in a complex protein liquid phase environment (serum). The device has the structural characteristics of chip formation and miniaturization, and can be used for detecting various types of high-throughput proteins at the same time.

The application belongs to the field of biomedicine, and particularly relates to application of CRYL1 protein in preparation of products for evaluating, diagnosing or assisting in diagnosing postoperative recurrence risk of calcium oxalate kidney stone combined with renal papillary calcium plaque, and a sequence of the CRYL1 protein is shown as SEQ ID NO. 1. The application firstly finds that expression of CRYL1 protein in renal tubular and collecting duct cells of renal papillary calcium plaque tissue is reduced, and it is proved through experiments that urine CRYL1 protein is a postoperative recurrence predictor and prediction marker of patients with CaOx kidney stone combined with renal papillary calcium plaque, and a CRYL1 protein detection kit is further developed for detecting or evaluating postoperative recurrence risk of patients with CaOx kidney stone combined with renal papillary calcium plaque, which promotes personalized follow-up and prevention scheme of the patients, and has great application prospect in the clinic.

An apparatus and method for identifying a protein or proteins in a sample of a biofluid. The identification is based on illuminating the sample with ultraviolet radiation and detecting and analyzing the resulting fluorescence. A trained model may be used to determine a protein responsible for a spectra detected from the illumination of the sample.

The invention relates to a sample analyzer, a protein analysis method and a protein analysis reagent. Preparing a first test solution by adopting a to-be-detected sample and the colorimetric method reagent, and detecting the first test solution by adopting a colorimetric method to obtain a colorimetric method detection result of the protein in the to-be-detected sample. Whether turbidimetric detection is carried out or not is judged on the basis of the colorimetric detection result, if not, the concentration of protein in the to-be-detected sample is determined on the basis of the colorimetric detection result, and if yes, a second test solution is prepared from the to-be-detected sample and a turbidimetric reagent, and the second test solution is detected through turbidimetry; and determining the concentration of the protein in the to-be-detected sample on the basis of the turbidimetric detection result and an optional colorimetric detection result. According to the present invention, the protein in the sample can be detected by integrating the colorimetric method and the turbidimetric method, and the linear detection range of the one-time protein detection is improved.

The present application relates to the field of biological science, and particularly relates to the use of a SCN11A protein detection reagent in the preparation of a depression screening and depression treatment effect evaluation kit. It is found for the first time that the expression level of SCN11A protein in the peripheral blood serum of a depression patient is significantly higher than that of a healthy subject. The reagent for detecting SCN11A protein is used in the preparation of a depression screening kit, so that effective screening of depression and evaluation of the treatment effect of depression can be realized.

A method for determining the presence of soluble, misfolded protein in or on the eye of a subject is described. The method includes contacting the eye of the subject with a monomeric protein to form an incubation mixture; incubating the incubation mixture to form a misfolded protein aggregate from the monomeric protein; and determining if a detectable amount of misfolded and / or aggregated protein is present in or on the eye; wherein detection of misfolded and / or aggregated protein indicates the presence of soluble, misfolded protein in the eye. Use of the method for diagnosing disease associated with protein misfolding in a subject is also described.

This invention relates to an organic electrochemical transistor for detecting protein-like substances, its preparation method, and its application, belonging to the field of protein detection technology. The organic electrochemical transistor for detecting protein-like substances of this invention includes a substrate, a source electrode, a drain electrode, a channel layer, an electrolyte, and a functionalized porous carbon-based gate. The source electrode and drain electrode are disposed parallel to each other on the substrate, forming a channel. The functionalized porous carbon-based gate includes a porous carbon-based gate, a self-assembled layer, and a protein-specific recognition layer stacked sequentially. The self-assembled layer is formed on the surface of the porous carbon-based substrate through the self-assembly of a carboxyl-containing thiol compound. The protein-specific recognition layer is covalently bonded to the surface of the self-assembled layer via amide bonds. The functionalized porous carbon-based gate achieves specific recognition of target protein-like substances through the protein-specific recognition layer. The organic electrochemical transistor of this invention exhibits good sensing stability, consistency, and high sensitivity.

The application discloses a nanobody targeting Claudin 18.2 and an application thereof, and belongs to the technical field of molecular biology. In view of the unique advantages of the nanobody in the prior art, the application provides a nanobody targeting Claudin 18.2, wherein the amino acid sequence of the nanobody is shown as SEQ ID NO. 1; the nanobody has strong affinity to 293T-Claudin 18.2 positive cells and can be combined with the Claudin 18.2 protein expressed on the cell surface. The nanobody targeting Claudin 18.2 provided by the application can be prepared by large-scale expression of an in-vitro engineering bacterium, can be applied to preparation of a protein detection antibody or a therapeutic antibody, can be used for in-vitro and in-vivo detection of tumor tissues expressing Claudin 18.2, and has important commercial value in clinical disease diagnosis and treatment.